Your browser doesn't support javascript.
loading
Thioredoxin-1 as a biological predictive marker for selecting diffuse large B-cell lymphoma patients for etoposide-containing treatment.
Kari, Esa Jarkko Mikael; Kuusisto, Milla Elvi Linnea; Honkavaara, Päivi; Hakalahti, Anna; Haapasaari, Kirsi-Maria; Bloigu, Risto; Karihtala, Peeter; Teppo, Hanna-Riikka; Pirinen, Risto; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi.
Afiliação
  • Kari EJM; Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland.
  • Kuusisto MEL; Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland.
  • Honkavaara P; Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland.
  • Hakalahti A; Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland.
  • Haapasaari KM; Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Bloigu R; Medical Informatics and Statistics Research Group, University of Oulu, Oulu, Finland.
  • Karihtala P; Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland.
  • Teppo HR; Cancer and Translational Medicine Research Unit, University of Oulu, Oulu, Finland.
  • Pirinen R; Department of Pathology, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Turpeenniemi-Hujanen T; Department of Pathology, North Karelia Central Hospital, Joensuu, Finland.
  • Kuittinen O; Department of Oncology and Radiotherapy, Medical Research Center, University of Oulu, Oulu University Hospital, Oulu, Finland.
Eur J Haematol ; 105(2): 156-163, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32248578
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiorredoxinas / Biomarcadores / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiorredoxinas / Biomarcadores / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Haematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Finlândia